Resumen: OBJECTIVES
There is a wide variety of predictive models of postoperative risk, although some of them are specific to thoracic surgery, none of them is widely used. The European Society for Thoracic Surgery has recently updated its models of cardiopulmonary morbidity (Eurolung 1) and 30-day mortality (Eurolung 2) after anatomic lung resection. The aim of our work is to carry out the external validation of both models in a multicentre national database.
METHODS
External validation of Eurolung 1 and Eurolung 2 was evaluated through calibration (calibration plot, Brier score and Hosmer–Lemeshow test) and discrimination [area under receiver operating characteristic curves (AUC ROC)], on a national multicentre database of 2858 patients undergoing anatomic lung resection between 2016 and 2018.
RESULTS
For Eurolung 1, calibration plot showed suboptimal overlapping (slope = 0.921) and a Hosmer–Lemeshow test and Brier score of P = 0.353 and 0.104, respectively. In terms of discrimination, AUC ROC for Eurolung 1 was 0.653 (95% confidence interval, 0.623–0.684). In contrast, Eurolung 2 showed a good calibration (slope = 1.038) and a Hosmer–Lemeshow test and Brier score of P = 0.234 and 0.020, respectively. AUC ROC for Eurolung 2 was 0.760 (95% confidence interval, 0.701–0.819).
CONCLUSIONS
Thirty-day mortality score (Eurolung 2) seems to be transportable to other anatomic lung-resected patients. On the other hand, postoperative cardiopulmonary morbidity score (Eurolung 1) seems not to have sufficient generalizability for new patients. Idioma: Inglés DOI: 10.1093/ejcts/ezac170 Año: 2022 Publicado en: EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY 62, 3 (2022), [8 pp.] ISSN: 1010-7940 Factor impacto JCR: 3.4 (2022) Categ. JCR: SURGERY rank: 39 / 213 = 0.183 (2022) - Q1 - T1 Categ. JCR: CARDIAC & CARDIOVASCULAR SYSTEMS rank: 63 / 143 = 0.441 (2022) - Q2 - T2 Categ. JCR: RESPIRATORY SYSTEM rank: 33 / 66 = 0.5 (2022) - Q2 - T2 Factor impacto CITESCORE: 5.7 - Medicine (Q1)